Pharma Journalist - Page 858 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria

Sanofi to acquire Protein Sciences

BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada)

Abzena and OBI Pharma Sign ThioBridge Licence Agreement

CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Center

InMed Pharmaceuticals Signs R&D Agreement with ATERA

Eurofins Has Signed an Exclusive Agreement to Acquire Amatsigroup

Zydus starts phase II trial of ZYAN1 for treating anemia in patients with CKD

FDA grants SOBI003 Orphan Drug Designation for the treatment of MPS IIIA

Exscientia Enters Strategic Drug Discovery Collaboration with GSK